10[10]Guidelines on diagnosis and management of acute pulmonary embolism. Fask Force on Pulmonary Embolism,European society of cardiology. Eur Heart J, 2000,21:1301
二级参考文献15
1程显声，Pulmonary embolism，1994年，25页
2程显声，肺血管疾病学，1993年，179页
3Goldhaber SZ. Contemporary pulmonary embolism thrombolysis.Chest, 1995 ,107(1 Suppl):45S-51S.
4Hyers TM, Agnelli G, Hull RD, et al.Antithrombotic therapy for venous thromboembolic disease.Chest, 2001,119(1 Suppl):176S-193S.
5Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology.Eur Heart J,2000,21:1301-1336.
6Konstantinides S, Geibel A, Olschewski M, et al.Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry.Circulation,1997,96:882-888.
7Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol,1997,80:184-188.
8Verstraete M, Miller GA, Bounameaux H, et al.Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism.Circulation,1988,77:353-360.
9Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.Arch Intern Med,1991,151:933-938.
